Are you looking for?
No Suggestions Found.
Detection of mutagenic derivatives of cyclophosphamide and a variety of other mutagens in a “microtitre”R fluctuation test, without microsomal activation ☆ ...
1. Teratog Carcinog Mutagen. 1985;5(2):75-88. Cyclophosphamide teratogenesis: a review. Mirkes PE. Cyclophosphamide (CP) is one of the best studied teratogens; it ...
Zemlickis et al: Teratogenicity and carcinogenicity in a twin exposed in utero to cyclophosphamide. Teratogenesis Carcinog Mutagen13:139-43, 1993.
An evaluation of the mode of action framework for mutagenic carcinogens case study: Cyclophosphamide † ‡
for evaluation of organ specificity of mutagens and for prediction of the carcinogenic effects of chemical compounds. Key Words: cyclophosphamide; mutagenic ...
An Evaluation of the Mode of Action Framework for Mutagenic Carcinogens Case Study: Cyclophosphamide An evaluation of the mode of action framework for mutagenic ...
May cause reproductive system effects. Carcinogen Mutagen Canada - WHMIS: Classifications Cyclophosphamide RCRA - U Series Wastes Waste Number U058
Cyclophosphamide must be metabolically activated to have maximal mutagenic or teratogenic activity. The first step in this activation is hydroxylation to ...
Environmental Mutagenesis 8:241-252 (1986). A Comparison of Mutagenic and. Embryotoxic Effects of Cyclophosphamide on the Chick Embryo ...
cyclophosphamide supplement, cyclophosphamide mutagen. bcmf, acrolein. Related Terms. info about prevacid otc, ketek. Sites. cephalosporins. pegfilgrastim dose
